Milestones In Basket Trials: Roche's VE-BASKET And 'My Pathway'
Executive Summary
Roche continues to invest in basket trials as tools to guide drug development. The "My Pathway" program expands from the one drug/one mutation focus of VE-BASKET to include four of the company's marketed oncologics.
You may also be interested in...
Keeping Track: Zelboraf Takes Breakthrough Path For Rare Blood Disease; Teva Resubmits Generic EpiPen
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: Zelboraf Takes Breakthrough Path For Rare Blood Disease; Teva Resubmits Generic EpiPen
The latest drug development news and highlights from our US FDA Performance Tracker.
Master Protocols In Practice
Basket trials are building a path for tissue-agnostic drug development in oncology, and plans are proceeding for more master protocols in pediatric cancers, acute myeloid leukemia and pancreatic cancer.